Drug-induced headache. Drug-induced headache, not elsewhere classified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: willing to participate in the study; age between 18 to 65; The absence of verbal and visual disorders; The absence of sensory-motor disorders; The absence of advanced neurological disorders; The absence of clotting problems, peripheral vascular disease, peripheral neuropathy and DVT limb; The absence of diagnosed psychiatric disorder; The absence of a headache before the administration of Nitroglycerine; the absence of any history of headache in patients; not having an addiction to drugs, sedatives, alcohol; Not using analgesics and nerve- muscle blockers 4 hours before the intervention; not having a long history of taking Nitroglycerine; The absence of history of using reflexology or acupressure; Not using of steroidal and non-steroidal anti-inflammatory drugs, anticoagulation, chemotherapy. Exclusion criteria: Incidence of severe complications during the study; Pain in other parts of the body other than the head; the severity of the pain so that the patient can not tolerate; Use analgesics drugs during the study; Dissatisfaction of attending physician or patient.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intensity of headache. Timepoint: Before the intervention , after the first intervention and after second intervention. Method of measurement: Visual Analog Pain Scale.;Quality of headache. Timepoint: Before the intervention, after the first intervention and after second intervention. Method of measurement: McGill Pain Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart rate. Timepoint: Before the intervention, after the first intervention and after second intervention. Method of measurement: Monitoring system.;Systolic Blood pressure. Timepoint: Before the intervention, after the first intervention and after second intervention. Method of measurement: Monitoring system.;Diastolic blood pressure. Timepoint: Before the intervention, after the first intervention and after second intervention. Method of measurement: Monitoring system.;Mean blood pressure. Timepoint: Before the intervention, after the first intervention and after second intervention. Method of measurement: Monitoring system.;Respiratory rate. Timepoint: Before the intervention, after the first intervention and after second intervention. Method of measurement: Monitoring system.;Oxygen saturation of arterial blood. Timepoint: Before the intervention, after the first intervention and after second intervention. Method of measurement: pulse oximeter. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shahed University